. CORRIGENDUM to 'Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN'. Cephalalgia 2021 May 5:3331024211015848. doi: 10.1177/03331024211015848.
PMID: 33951947